These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 24860174

  • 1. Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction.
    Ghazanfari N, Morsch M, Reddel SW, Liang SX, Phillips WD.
    J Physiol; 2014 Jul 01; 592(13):2881-97. PubMed ID: 24860174
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN, Reddel SW, Gervásio OL, Phillips WD.
    Ann Neurol; 2008 Jun 01; 63(6):782-9. PubMed ID: 18384168
    [Abstract] [Full Text] [Related]

  • 5. Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody.
    Morsch M, Reddel SW, Ghazanfari N, Toyka KV, Phillips WD.
    J Physiol; 2013 May 15; 591(10):2747-62. PubMed ID: 23440963
    [Abstract] [Full Text] [Related]

  • 6. Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravis.
    Ghazanfari N, Linsao EL, Trajanovska S, Morsch M, Gregorevic P, Liang SX, Reddel SW, Phillips WD.
    Physiol Rep; 2015 Dec 15; 3(12):. PubMed ID: 26702075
    [Abstract] [Full Text] [Related]

  • 7. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
    Koneczny I, Cossins J, Waters P, Beeson D, Vincent A.
    PLoS One; 2013 Dec 15; 8(11):e80695. PubMed ID: 24244707
    [Abstract] [Full Text] [Related]

  • 8. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM, Van Den Broeck J, Vrolix K, Janssen SP, Lemmens MA, Van Der Esch E, Duimel H, Frederik P, Molenaar PC, Martínez-Martínez P, De Baets MH, Losen M.
    Autoimmunity; 2010 Aug 15; 43(5-6):353-70. PubMed ID: 20380584
    [Abstract] [Full Text] [Related]

  • 9. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
    Farrugia ME, Bonifati DM, Clover L, Cossins J, Beeson D, Vincent A.
    J Neuroimmunol; 2007 Apr 15; 185(1-2):136-44. PubMed ID: 17335909
    [Abstract] [Full Text] [Related]

  • 10. Rapsyn carboxyl terminal domains mediate muscle specific kinase-induced phosphorylation of the muscle acetylcholine receptor.
    Lee Y, Rudell J, Yechikhov S, Taylor R, Swope S, Ferns M.
    Neuroscience; 2008 Jun 02; 153(4):997-1007. PubMed ID: 18436384
    [Abstract] [Full Text] [Related]

  • 11. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K, Kubo S, Jie C, Hato N, Abe Y, Ueda N, Kobayashi N, Kameda K, Mominoki K, Miyazawa A, Ishigami A, Matsuda S, Maruyama N.
    Ann N Y Acad Sci; 2008 Jun 02; 1132():93-8. PubMed ID: 18096854
    [Abstract] [Full Text] [Related]

  • 12. Anti-MuSK autoantibodies block binding of collagen Q to MuSK.
    Kawakami Y, Ito M, Hirayama M, Sahashi K, Ohkawara B, Masuda A, Nishida H, Mabuchi N, Engel AG, Ohno K.
    Neurology; 2011 Nov 15; 77(20):1819-26. PubMed ID: 22013178
    [Abstract] [Full Text] [Related]

  • 13. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.
    Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, Melms A, Kröger S.
    J Neurol; 2012 Mar 15; 259(3):427-35. PubMed ID: 21814823
    [Abstract] [Full Text] [Related]

  • 14. [Anti-MuSK antibodies in myasthenia gravis block binding of collagen Q to MuSK].
    Ohno K.
    Rinsho Shinkeigaku; 2012 Mar 15; 52(11):1306-8. PubMed ID: 23196600
    [Abstract] [Full Text] [Related]

  • 15. Roles of rapsyn and agrin in interaction of postsynaptic proteins with acetylcholine receptors.
    Fuhrer C, Gautam M, Sugiyama JE, Hall ZW.
    J Neurosci; 1999 Aug 01; 19(15):6405-16. PubMed ID: 10414969
    [Abstract] [Full Text] [Related]

  • 16. Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.
    Otsuka K, Ito M, Ohkawara B, Masuda A, Kawakami Y, Sahashi K, Nishida H, Mabuchi N, Takano A, Engel AG, Ohno K.
    Sci Rep; 2015 Sep 10; 5():13928. PubMed ID: 26355076
    [Abstract] [Full Text] [Related]

  • 17. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
    Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, Beeson D, Willcox N, Vincent A.
    Brain; 2008 Jul 10; 131(Pt 7):1940-52. PubMed ID: 18515870
    [Abstract] [Full Text] [Related]

  • 18. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
    Shiraishi H, Motomura M, Yoshimura T, Fukudome T, Fukuda T, Nakao Y, Tsujihata M, Vincent A, Eguchi K.
    Ann Neurol; 2005 Feb 10; 57(2):289-93. PubMed ID: 15668981
    [Abstract] [Full Text] [Related]

  • 19. Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients.
    Takata K, Stathopoulos P, Cao M, Mané-Damas M, Fichtner ML, Benotti ES, Jacobson L, Waters P, Irani SR, Martinez-Martinez P, Beeson D, Losen M, Vincent A, Nowak RJ, O'Connor KC.
    JCI Insight; 2019 Jun 20; 4(12):. PubMed ID: 31217355
    [Abstract] [Full Text] [Related]

  • 20. Induction of myasthenia by immunization against muscle-specific kinase.
    Shigemoto K, Kubo S, Maruyama N, Hato N, Yamada H, Jie C, Kobayashi N, Mominoki K, Abe Y, Ueda N, Matsuda S.
    J Clin Invest; 2006 Apr 20; 116(4):1016-24. PubMed ID: 16557298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.